RBC Upgrades SAGE Therapeutics to Sector Perform From Underperform, Keeps Speculative Risk, $4 Price Target
RBC Upgrades SAGE Therapeutics to Sector Perform From Underperform, Keeps Speculative Risk, $4 Price Target
RBC将sage therapeutics评级从表现欠佳上调至板块表现，维持投机风险，目标价格4美元。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间